Vargatef
CAS: 1160294-26-7
Ref. 3D-KWB29426
| 25mg | 136,00 € | ||
| 50mg | 172,00 € | ||
| 100mg | 232,00 € | ||
| 250mg | 453,00 € | ||
| 500mg | 645,00 € |
Informação sobre produto
- 2,3-Dihydro-3[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester
Nintedanib is a medicinal inhibitor that targets cancer cells by inhibiting protein kinases. It has been shown to be effective against various types of tumors, including leukemia. Nintedanib exerts its anti-cancer effects by disrupting the cell cycle and inducing apoptosis in tumor cells. This drug has been tested on human cancer cell lines and has shown promising results in inhibiting tumor growth. Additionally, studies have shown that nintedanib can inhibit angiogenesis, which is the formation of new blood vessels that supply nutrients to tumors. This makes it a potential treatment for cancers that rely on angiogenesis for their growth.
Propriedades químicas
Consulta técnica sobre: 3D-KWB29426 Vargatef
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
